CELL
PhenomeX Inc. Common Stock
CELL
CELL
Delisted
CELL was delisted on the 29th of September, 2023.
129 hedge funds and large institutions have $348M invested in PhenomeX Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 45 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
61% less capital invested
Capital invested by funds: $899M → $348M (-$550M)
Holders
129
Holding in Top 10
2
Calls
$879K
Puts
$869K
Top Buyers
| 1 | +$13.5M | |
| 2 | +$11.3M | |
| 3 | +$8.48M | |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$8.26M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.8M |
Top Sellers
| 1 | -$19.8M | |
| 2 | -$15.6M | |
| 3 | -$14.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.29M |